These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Syncope in a patient with Wolff-Parkinson-White syndrome and inducible ventricular fibrillation. Klein LS Chest; 1986 Jun; 89(6):875-9. PubMed ID: 3086047 [No Abstract] [Full Text] [Related]
27. Atrial fibrillation: an increasingly common and provocative arrhythmia. Futterman LG; Lemberg L Am J Crit Care; 1996 Sep; 5(5):379-87. PubMed ID: 8870863 [No Abstract] [Full Text] [Related]
28. [Pharmacological profile of a new anti-arrhythmia agent: bunaftide]. Beani L Boll Soc Ital Cardiol; 1972; 17(12):1279-81. PubMed ID: 4681455 [No Abstract] [Full Text] [Related]
29. Prophylactic lidocaine in acute myocardial infarction: resurface or reburial? Yadav AV; Zipes DP Am J Cardiol; 2004 Sep; 94(5):606-8. PubMed ID: 15342291 [No Abstract] [Full Text] [Related]
30. Antiarrhythmic therapy for the prevention of sudden cardiac death. Cairns J; Kerr C; Teo K Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276 [No Abstract] [Full Text] [Related]
31. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation. Kilborn MJ; Rathore SS; Gersh BJ; Oetgen WJ; Solomon AJ Am Heart J; 2002 Dec; 144(6):1095-101. PubMed ID: 12486436 [TBL] [Abstract][Full Text] [Related]
32. [Antiarrhythmic drugs in atrial fibrillation]. Brembilla-Perrot B Rev Prat; 2002 Jun; 52(12):1317-23. PubMed ID: 12187895 [TBL] [Abstract][Full Text] [Related]
33. [Electrocardiographic aspects of atrial damage in the course of myocardial infarct. Study of 615 cases]. Giorgetti C; Trivella U; Chiaverini P; Danisi M Boll Soc Ital Cardiol; 1968; 13(1):1-9. PubMed ID: 5705763 [No Abstract] [Full Text] [Related]
34. [Risk of ventricular fibrillation in patients with Wolff-Parkinson White syndrome]. Bootsma M; van der Wall EE; Schalij MJ Ned Tijdschr Geneeskd; 2003 Apr; 147(15):708-14. PubMed ID: 12722534 [TBL] [Abstract][Full Text] [Related]
35. [Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis]. Niakara A; Nébié LV; Samadoulougou AK; Kaboré NJ; Ouandaogo BJ; Drabo YJ Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):113-7; discussion 118. PubMed ID: 12555335 [TBL] [Abstract][Full Text] [Related]
36. Precipitation of ventricular fibrillation by intravenous diltiazem and metoprolol in a young patient with occult Wolff-Parkinson-White syndrome. Kim RJ; Gerling BR; Kono AT; Greenberg ML Pacing Clin Electrophysiol; 2008 Jun; 31(6):776-9. PubMed ID: 18507555 [TBL] [Abstract][Full Text] [Related]
37. ["Arrhythmica" or: history, extent and practical consequences of pro-arrhythmia effects]. Gertsch M Schweiz Med Wochenschr; 1996 Apr; 126(14):566-75. PubMed ID: 8668970 [TBL] [Abstract][Full Text] [Related]
38. [Electrophysiologic study of propafenon in Wolff-Parkinson-White syndrome]. Clémenty J; Sourdille N; Pedeboscq G; Bricaud H Ann Cardiol Angeiol (Paris); 1982; 31(5):351-5. PubMed ID: 7158983 [No Abstract] [Full Text] [Related]
39. Drug therapy for atrial fibrillation. Musco S; Conway EL; Kowey PR Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001 [TBL] [Abstract][Full Text] [Related]